EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms and Clinical Implications—A Narrative Review

Héctor Fuentes-Barría iD, Raúl Aguilera-Eguía iD, Miguel Alarcón-Rivera iD, Lisse Angarita-Davila iD, Cherie Flores-Fernández iD

International Journal of Molecular Sciences · 10.03.2026 · 27 (6) · 2532

DOI: 10.3390/ijms27062532 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.03.2026. Verfasst von Héctor Fuentes-Barría und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Medicina de Altura (CEIMA), Universidad Arturo Prat, Iquique 1110939, Chile. Hauptthemen laut MEDLINE: Vitamin D, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D has been extensively investigated for its role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a chronic condition characterized by hepatic steatosis, insulin resistance, inflammation, and metabolic dysregulation. This review examines the molecular mechanisms through which vitamin D influences liver metabolism, insulin signaling, lipid accumulation, and inflammatory pathways while evaluating its potential clinical applications in MASLD management. In its active form, 1,25-dihydroxyvitamin D3, vitamin D modulates hepatocyte function by reducing proinflammatory cytokines, enhancing insulin sensitivity, activating AMPK signaling, inhibiting mTOR pathways, and regulating lipid homeostasis. These effects contribute to decreased hepatic fat deposition and improved metabolic profiles, which are key in MASLD progression. Evidence also suggests that vitamin D supplementation may improve liver enzymes, insulin resistance, and lipid parameters in patients with MASLD, although responses vary depending on dosage, baseline vitamin D status, and patient characteristics. Despite promising findings, inconsistencies in study design, measurement methods, and population differences underscore the need for standardized approaches and personalized strategies. In conclusion, vitamin D demonstrates complementary therapeutic potential in MASLD, highlighting research gaps related to optimal dosing, duration, and long-term outcomes. Future studies should integrate mechanistic insights with clinical trials to optimize vitamin D’s role in improving liver and metabolic health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DFatty LiverNon-alcoholic Fatty Liver DiseaseHumansAnimalsInsulin ResistanceLipid MetabolismLiverSignal Transduction

Stichwörter der Autor:innen

fatty livermolecular biologynon-alcoholic fatty liver diseasevitamin D

Substanzen

Vitamin D

Autor:innen und Institutionen

  • Centro de Investigación en Medicina de Altura (CEIMA), Universidad Arturo Prat, Iquique 1110939, Chile.
  • Departamento de Salud Pública, Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción 3349001, Chile.
  • Escuela de Ciencias del Deporte y Actividad Física, Facultad de Salud, Universidad Santo Tomas, Talca 3460000, Chile.
  • Escuela de Nutrición y Dietética, Facultad de Medicina, Universidad Andres Bello, Concepción 3349001, Chile.
  • Departamento de Gestión de la Información, Universidad Tecnológica Metropolitana, Santiago 7550000, Chile.

ORCID-Profile: Héctor Fuentes-Barría, Raúl Aguilera-Eguía, Miguel Alarcón-Rivera, Lisse Angarita-Davila, Cherie Flores-Fernández

Zitieren

APA

Fuentes-Barría, H., Aguilera-Eguía, R., Alarcón-Rivera, M., Angarita-Davila, L., & Flores-Fernández, C. (2026). Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms and Clinical Implications—A Narrative Review. International Journal of Molecular Sciences, 27(6), 2532. https://doi.org/10.3390/ijms27062532

Vancouver

Fuentes-Barría H, Aguilera-Eguía R, Alarcón-Rivera M, Angarita-Davila L, Flores-Fernández C. Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms and Clinical Implications—A Narrative Review. International Journal of Molecular Sciences. 2026;27(6):2532. doi:10.3390/ijms27062532

BibTeX
@article{FuentesBarra2026,
  author = {Fuentes-Barría, Héctor and Aguilera-Eguía, Raúl and Alarcón-Rivera, Miguel and Angarita-Davila, Lisse and Flores-Fernández, Cherie},
  title = {Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms and Clinical Implications—A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2532},
  doi = {10.3390/ijms27062532}
}
Kostenlos starten →